Back to search
CLDN18.2-positive Advanced Biliary Tract Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which CLDN18.2-positive Advanced Biliary Tract Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which CLDN18.2-positive Advanced Biliary Tract Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
In this clinical study, we will evaluate the efficacy and safety of cardonilimumab (PD1 monoclonal antibody and CTLA-4 monoclonal antibody bisspecific antibodie…
This is an open-label, multicenter Phase II clinical study aimed at evaluating the efficacy, safety, PK profile, and immunogenicity of QLS31905 for Injection co…